1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA YY1 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA KIF2A CTRPv2 pan-cancer AAC 0.13 0.002
mRNA PALM CTRPv2 pan-cancer AAC 0.12 0.003
mRNA ZNF66 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA KIF19 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA CYP4F22 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA HOXA9 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA DAZAP1 CTRPv2 pan-cancer AAC 0.13 0.003
mRNA TTC39B CTRPv2 pan-cancer AAC 0.11 0.003
mRNA INTS6L CTRPv2 pan-cancer AAC 0.13 0.003
Download CSV